Literature DB >> 12946756

Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term results.

Hannes Steiner1, Lorenz Höltl, Christoph Maneschg, Andreas P Berger, Hermann Rogatsch, Georg Bartsch, Alfred Hobisch.   

Abstract

OBJECTIVES: To evaluate retrospectively the indications, surgical technique, feasibility, and follow-up data of our frozen section analysis-guided organ-sparing approach to small testicular tumors. Removal of a solitary testis or bilateral orchiectomy for testicular neoplasm results in androgen deprivation and infertility. Moreover, removal of a testis for benign lesions is to be avoided. Organ-sparing surgery aims at preserving enough testicular parenchyma to maintain physiologic endocrine function and, if possible, fertility.
METHODS: Tumors of 25 mm or less in diameter were managed by an organ-sparing approach. Normal preoperative plasma levels of luteinizing hormone and testosterone were a prerequisite. After localization of the tumor by ultrasonography and accurate staging, organ-sparing surgery was performed under cold ischemia. Frozen section analyses of the tumor and tumor bed biopsies were obtained. In the case of malignant germ cell tumor with a normal contralateral testis, ablation of the tumor-bearing testis was performed.
RESULTS: A total of 32 organ-preserving procedures were performed in 30 patients without any complications. Local recurrence was observed in 1 patient who refused to undergo local radiotherapy for concomitant testicular intraepithelial neoplasia; repeat organ-sparing surgery was performed in this patient. After organ-sparing surgery, ablation of the remaining testis was performed in 1 patient because of positive margins on final histologic analysis and in another patient because of endocrine insufficiency. In all other patients, the serum testosterone levels remained within normal limits. No retroperitoneal, pulmonary, or other recurrences were encountered; all patients were free of disease at a mean follow-up of 46.3 months.
CONCLUSIONS: The organ-sparing frozen section analysis-guided approach to testicular masses represents a promising treatment alternative to orchiectomy in selected patients with bilateral malignant testicular tumors, tumors in a solitary testis, or unilateral or bilateral benign tumors. The technique is oncologically efficient, lifelong hormonal substitution can be prevented, and, in some patients, even fertility may be preserved, provided certain criteria concerning patient selection and surgical technique are observed.

Entities:  

Mesh:

Year:  2003        PMID: 12946756     DOI: 10.1016/s0090-4295(03)00465-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  21 in total

1.  Organ-sparing surgery for large cell calcifying Sertoli cell tumour in a patient with Carney complex.

Authors:  Maria José Freire; Pedro Nunes; Luà S Sousa; Arnaldo Figueiredo
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Testis-sparing surgery of unilateral testicular large-cell calcifying Sertoli cell tumor: a sporadic case.

Authors:  Eyyüp Sabri Pelit; Bülent Erol; Tülay Zenginkinet; Turhan Çaşkurlu
Journal:  Turk J Urol       Date:  2018-07

Review 3.  [Organ-sparing surgery for testicular tumors].

Authors:  L Weissbach; C Schaefer
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

Review 4.  [Organ-sparing therapy for testicular cancer].

Authors:  C Breunig; M Schrader; A J Schrader; F Zengerling
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

5.  Testis-sparing surgery for testicular tumors in children: a 20 year single center experience and systematic review of the literature.

Authors:  Juan I Bois; Roberto L Vagni; Francisco I de Badiola; Juan M Moldes; Paul D Losty; Pablo A Lobos
Journal:  Pediatr Surg Int       Date:  2021-01-17       Impact factor: 1.827

6.  Is testis-sparing surgery safe in small testicular masses? Results of a multicentre study.

Authors:  Murat Keske; Abdullah Erdem Canda; Serdar Yalcin; Aydan Kilicarslan; Yusuf Kibar; Can Tuygun; Evrim Onder; Ali Fuat Atmaca; Asif Yildirim; Sidika Seyma Ozkanli; Olcay Kandemir; Taner Kargi; Mehmet Sar; Volkan Tugcu; Berkan Resorlu; Yilmaz Aslan; Selcuk Sarikaya; Ugur Boylu; Ali Fuat Cicek; Halil Basar; Altug Tuncel; Mevlana Derya Balbay
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

7.  Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study.

Authors:  Florian Laclergerie; Guillaume Mouillet; Alexandre Frontczak; Loïc Balssa; Pascal Eschwege; Christian Saussine; Stéphane Larré; Luc Cormier; Antoine Thiery Vuillemin; François Kleinclauss
Journal:  World J Urol       Date:  2017-12-11       Impact factor: 4.226

Review 8.  Testis-preserving strategies in testicular germ cell tumors and germ cell neoplasia in situ.

Authors:  Pia Paffenholz; David Pfister; Axel Heidenreich
Journal:  Transl Androl Urol       Date:  2020-01

9.  Organ-sparing surgery is the treatment of choice in benign testicular tumors.

Authors:  Nicolai Leonhartsberger; Renate Pichler; Brigitte Stoehr; Wolfgang Horninger; Hannes Steiner
Journal:  World J Urol       Date:  2013-10-04       Impact factor: 4.226

10.  Pilomatrixoma-like testicular tumour without teratomatous elements.

Authors:  Dinç Süren; Mustafa Yıldırım; Bekir Erol; Birsel Tutuş
Journal:  BMJ Case Rep       Date:  2014-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.